1 Min Read
* SENZAGEN SIGNS KEY LICENSE AGREEMENT IN THE US WITH BURLESON RESEARCH TECHNOLOGIES
* BRT WILL MARKET AND PROVIDE GARD IN US AND PERFORM TEST IN ITS LABORATORY IN NORTH CAROLINA Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.